1Merveiel P, Evain-Brion D, Challoer JC, et al. The molecular ba-sis of embryo implantation in humans. Zentralbl Gynakol,2001,123 :328-329.
2Huppertz B, Kertschanska S, Demir AY, et al. lmmunohistoche-mistry of matrix metalloproteinases ( MMP), their substrates, andtheir inhibitors (TIMP) during trophoblast invasion in the humanplacenta. Cell Tissue Res, 1998,291 : 133-148.
3Wang H, Li Q, Shao L, et al. Expression ofmatrixmetallopro-teinase-2,- 9,-14, and tissue inhibitors ofmetalllopro-teinase-1 ,-2,-3 in the endometrium and placenta of rhesus monkey (Maeaeamulatta)during early pregnancy. Biology of Reproduction, 2001,65 : 31-40.
5Tikkanen M, Nuutila M, Hiilesmaa V,Paavonen J, Ylikorkala O. Clinical presentation and risk factors of placental abruption[J]. Acta Obstet Gynecol Scand,2006,85 (6) :700 - 705.
6Dafallah SE ,Babikir HE. Risk factors predisposing to abruption placentae. Maternal and fetal outcome[J]. Saudi Med J,2004,25(9) : 1237 - 1240.
7Abu Heija A, Al Chalabi H, El llouban iN. Abruption placentae : risk factors and perinatal outcome [ J ]. J Obstet Gynaecol Res, 1998,24 (2) : 141 - 144.
8李笑天.胎盘早剥[M].丰有吉.妇产科学.1版.北京:人民卫生出版社,2005.88.
9Ananth CV, Getahun D, Pehier MR, Smulian JC. Placental abruption in term and preterm gestations:evidence for heterogeneity in clinical pathways[J]. Obstet Gynecol,2006,107(4) :785 -792.
10Sanchez SE, Pacora PN,Farfan JH, Fernandez A,Qiu C, Ananth CV, Williams MA. Risk factors of abruption placentae among Peruvian women[ J]. Am J Obstet Gynecol,2006,194 ( 1 ) :225 - 230.
